Despite strong guidance and pipeline, the stock fell due to disappointment on the quarterly product mix. Analysts were surprised by the weakness versus consensus for several key growth drivers.
White House calls for adequate production of RSV vaccines emphasizing the importance of access for families. AstraZeneca admits Beyfortus demand surpasses previous standards, highlighting its market importance amid rising U.S. RSV cases.
$ASTRAZENECA PLC(AZNCF.US)$ — Shares rose 1.4% after Jefferies upgraded the stock to buy from hold. The upgrade comes after one of its breast cancer therapies, in joint development with Daiichi Sankyo, came out with positive results in a late-stage trial on Friday. $アーバン アウトフィッターズ(URBN.US)$,$フット ロッカー(FL.US)$ — Shares of Urban Outfitters fell 4%, while Foot Locker slid 2.9% before the bell after Jefferies downgraded the stocks to hold from...
$ASTRAZENECA PLC(AZNCF.US)$ — Shares of the British pharmaceutical company gained more$ウェイフェア A(W.US)$than 2.7% in premarket trading after the company reported positive results for its drug Dato-DXd in a trial for treating a common type of breast cancer. $ウェイフェア A(W.US)$ — Shares gained more than 2% after Bernstein upgraded home merchandiser to market perform from underperform. The firm cited improving revenue growth and margin commentary. Chinese e-commer...
Pre-Market Stock Movers Gapping up $インテル(INTC.US)$ (Shares popped 6.7% after the chipmaker posted better-than-expected second-quarter results and a return to profitability after two consecutive losing periods. Intel’s forecast for the third quarter also came in above analyst expectations. The company reported adjusted earnings of 13 cents a share on revenues of $12.95 billion.) $ロク(ROKU.US)$ (The streaming stock...
1. Introduction As investors evaluate potential sectors for their next moves in the midst of the 2023 market outlook, healthcare emerges as an attractive option. This post explores three compelling reasons why healthcare warrants consideration: its defensive nature in the face of a looming recession, its historical tendency to perform better in the second half of the year, and the recent corrections in major healthcare tickers, presenting f...
Pre-Market Stock Movers Gapping up $リビアン オートモーティブ(RIVN.US)$+6.5% (Rivian popped 6.5% in premarket trading, adding to Monday's gains after the electric vehicle maker reported 12,640 deliveries during the second quarter. The deliveries were up 59% from the previous quarter and beat analyst expectations of 11,000 vehicles, according to StreetAccount.) $ASTRAZENECA PLC(AZNCF.US)$+3% (The drugmaker climbed nearly 3%...
ASTRAZENECA PLCに関するコメント
📊⚡️📊
Hope miracle happens suddenly shows up an acquisition news like $Gracell Biotechnologies(GRCL.US)$ by ...
$Gracell Biotechnologies(GRCL.US)$
$ASTRAZENECA PLC(AZNCF.US)$
$アストラゼネカ(AZN.US)$
— Shares rose 1.4% after Jefferies upgraded the stock to buy from hold. The upgrade comes after one of its breast cancer therapies, in joint development with Daiichi Sankyo, came out with positive results in a late-stage trial on Friday.
$アーバン アウトフィッターズ(URBN.US)$, $フット ロッカー(FL.US)$
— Shares of Urban Outfitters fell 4%, while Foot Locker slid 2.9% before the bell after Jefferies downgraded the stocks to hold from...
— Shares of the British pharmaceutical company gained more $ウェイフェア A(W.US)$ than 2.7% in premarket trading after the company reported positive results for its drug Dato-DXd in a trial for treating a common type of breast cancer.
$ウェイフェア A(W.US)$
— Shares gained more than 2% after Bernstein upgraded home merchandiser to market perform from underperform. The firm cited improving revenue growth and margin commentary.
Chinese e-commer...
Gapping up
$インテル(INTC.US)$
(Shares popped 6.7% after the chipmaker posted better-than-expected second-quarter results and a return to profitability after two consecutive losing periods. Intel’s forecast for the third quarter also came in above analyst expectations. The company reported adjusted earnings of 13 cents a share on revenues of $12.95 billion.)
$ロク(ROKU.US)$
(The streaming stock...
As investors evaluate potential sectors for their next moves in the midst of the 2023 market outlook, healthcare emerges as an attractive option. This post explores three compelling reasons why healthcare warrants consideration: its defensive nature in the face of a looming recession, its historical tendency to perform better in the second half of the year, and the recent corrections in major healthcare tickers, presenting f...
Gapping up
$リビアン オートモーティブ(RIVN.US)$ +6.5% (Rivian popped 6.5% in premarket trading, adding to Monday's gains after the electric vehicle maker reported 12,640 deliveries during the second quarter. The deliveries were up 59% from the previous quarter and beat analyst expectations of 11,000 vehicles, according to StreetAccount.)
$ASTRAZENECA PLC(AZNCF.US)$ +3% (The drugmaker climbed nearly 3%...
まだコメントはありません